Chart Industries to Present at Bank of America Securities Global Industrials Conference
ATLANTA, March 06, 2024 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a leading global solutions provider to clean […]
THOR Industries Announces Second Quarter Fiscal 2024 Results
ANTICIPATES STRONGER PERFORMANCE IN THE SECOND HALF OF FISCAL 2024 WHILE LOWERING FISCAL 2024 GUIDANCE TO REFLECT COMPANY’S PRUDENT FOCUS […]
Tyson Ventures Invites Startups to Apply for Tyson Demo Day 2024
SPRINGDALE, Ark., March 06, 2024 (GLOBE NEWSWIRE) — Tyson Ventures, the venture capital arm of Tyson Foods (NYSE: TSN), is […]
Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024
Boston, March 06, 2024 (GLOBE NEWSWIRE) — Amwell® (NYSE: AMWL), a leader in hybrid care enablement, is attending HIMSS 2024, […]
Sunlands Technology Group to Report Fourth Quarter and Full Year 2023 Financial Results on Friday, March 22, 2024
BEIJING, March 06, 2024 (GLOBE NEWSWIRE) — Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s […]
Health technology leader Philips recognized as Clarivate Top 100 Global Innovator
March 6, 2024 Company’s innovative products and solutions improved the lives of 1.9 billion people in 2023 Amsterdam, the Netherlands […]
Vishay Intertechnology Acquires Nexperia’s Newport Wafer Fab for $177 Million
MALVERN, Pa., March 06, 2024 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today announced that it has completed the […]
Rogers Communications Inc. Files Annual Report to Shareholders
TORONTO, March 05, 2024 (GLOBE NEWSWIRE) — Rogers Communications Inc. (TSX: RCI.A and RCI.B; NYSE: RCI) (“Rogers”) today announced the […]
CoreCivic Announces Upsizing and Pricing of $500 Million 8.25% Senior Notes Due 2029
BRENTWOOD, Tenn., March 05, 2024 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (“CoreCivic”) announced today that it successfully upsized and […]
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting
Preclinical data support future clinical development of ADCs targeting Claudin-6 and NaPi2b Additional presentations include clinical and independent preclinical studies […]
